Actionable genomic information for accurate diagnosis for metastatic patients with diagnostic
An accurate tumor type diagnosis is the first step in precision oncology.
Distinguishes between 50 tumor types
Identifies tumor types not previously considered
Most widely adopted gene expression test for diagnosis of unknown or uncertain tumors
Requires small tumor sample (~300 cells)
Treatment recommendations changed in 47% of patients based on incorporation of test results (more)^
Test results available within 5 business days
(from receipt of specimen and required information)
Most validated gene expression test
100% covered by Medicare
Helping 7,500 physicians and 32,000 metastatic patients for over 8 years
CancerTYPE ID: Mechanism of Action
The Most Important Aspect to Treating Tumors
^ NeoTYPE Cancer Profiles are performed and billed separately by our contracted reference laboratory, NeoGenomics Laboratories, Inc.